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Changes are described that are brought about by antimycin, NoHOQnO, funicuiosin, myxothiazol and mu- 
cidin in the c+, /3- and y-absorption bands of reduced and oxidized cytochromes b in the isolated complex 
bc, form beef heart mitochondria. The inhibitors can be divided into 2 groups. Antimycin, funiculosin and 
NoHOQnO are likely to shift the spectrum of b-562 and compete for specific binding with complex bc,, 
with each other but not with myxothiazol and mucidin. The spectral effects of the latter two inhibitors are 
more difficult to interpret and may involve contributions not only from b-562 but from b-566 as well. The 
existence of 2 independent inhibitor binding-sites in the complex bc, corroborates the Q-cycle hypothesis. 
Cytoehrome b Q cycle Spectral shifr 
1. INTRODUCTION 
Electron transfer in the ubiquinol : cytochrome c 
oxidoreductase segment of the mitochondrial 
respiratory chain is blocked specifically by a 
number of antibiotics such as antimycin, 
2-alkyl-4-hydroxyquinoline N-oxide, funiculosin, 
mucidin, myxothiazol, as well as by many syn- 
thetic CoQ antagonists (review [I-3]). These in- 
hibitors are specific ligands of the cytochrome be1 
complex and can be ~ticipated to affect certain 
characteristics of the redox centres involved in the 
reactions inhibited. Indeed, funiculosin, NoHO- 
QnO and myxothiazol have been shown recently to 
modulate midpoint redox potentials of mitochon- 
drial b cytochromes [4]. Here we are concerned 
with the effects of the bcl inhibitors on the optical 
absorption spectra of b cytochromes. 
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Earlier studies on this point were confined to the 
a-band of the reduced cytochromes 6. It has been 
generally agreed that antimycin shifts the a-peak 
of ferrocytochrome b-562 to the red by less than 
1 nm [5]. As regards other inhibitors, the pub- 
lished data are much less consistent or sometimes 
controversial (e.g., cf. [6-9]), which can be due in 
part to different objects or preparations used in 
different laboratories. 
Here we describe optical absorption difference 
spectra induced by antimycin, NoHOQnO, 
funiculosin, myxothiazol and mucidin in the LY-, & 
and y-bands of the reduced and oxidized b- 
cytochromes in the isolated cytochrome bcl com- 
plex from bovine heart. The spectral effects of the 
antibiotics were used subsequently to study com- 
petition between them for binding with complex 
bc, . 
2. METHODS 
Cytochrome be1 complex was isolated from beef 
heart mitochondria according to Rieske [lo]. An- 
timycin and NoHOQnO were from Serva. 
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Mucidin, myxothiazol and funiculosin were kind 
gifts from Dr V. Musilek (Institute of 
Microbiology Acad. Sci. CSSR, Prague), Dr W. 
Trowitzch (Gesellschaft fur Biotechnologische 
Forschung, Braunschweig) and Dr P. Bollinger 
(Sandoz, Basel). Other chemicals were commercial 
products of the purest grade available from Sigma, 
Serva and Merck. Optical measurements were 
made in an Aminco DW2a spectrophotometer at a 
slit width of 2 nm in rectangular 10 mm cells ther- 
mostatted at 25°C. The basic medium contained 
0.3 M sucrose, 30 mM Hepes-NaOH (pH 7.5), 
0.02% Na-cholate, and 1 mM EDTA. The same 
medium, but without cholate, was used in the ex- 
periments with SMP. In the experiments with the 
oxidized complex bcr, 0.3 mM ferricyanide was 
added; reduction of the cytochromes was achieved 
with small amounts of solid dithionite. Typically, 
experiments were performed as follows: the oxi- 
dized or reduced suspension of complex bcr 
(0.5 mg protein/ml) was divided between the sam- 
ple and reference cells. After correction of the 
baseline, an inhibitor was added to the sample and 
an equal volume of the solvent (ethanol or dime- 
thylsulfoxide) to the reference and after 2-3 min 
incubation the difference spectrum was recorded. 
Subsequent addition of the inhibitor to the 
reference always cancelled the absorption 
difference. 
3. RESULTS AND DISCUSSION 
Typical difference spectra observed upon addi- 
tion of various inhibitors to the reduced and ox- 
idized cytochrome bcr complex are shown in figs 1 
and 2. Very similar difference spectra have also 
been obtained in experiments with submitochon- 
drial particles [ 11,121. In the reduced complex bcr , 
all the antibiotics tested bring about well defined 
spectral changes in the LY-, P- and y-absorption 
bands (fig.1). In the oxidized preparation, the ef- 
fects were generally of a smaller size so that in the 
visible region only antimycin induced a discernible 
difference spectrum (spectra a, dotted line, in 
fig.lA); however, in the Soret region the spectral 
changes were quite significant (fig.2). Comprehen- 
sive discussion of the spectral effects induced by 
various inhibitors will be given presently in con- 
junction with magnetic circular dichroism studies 
carried out in collaboration with Dr A.M. Arut- 
96 
junjan’s laboratory ([13], in preparation). Some 
comments on the results are given below. 
First of all, it is likely that all the difference spec- 
tra induced by the inhibitors are associated 
predominantly with cytochromes b since in all 
cases they are located around the maxima of the 
corresponding absorption bands of these 
hemoproteins. 
The effects of antimycin and funiculosin are 
mirror images of each other throughout the entire 
spectral range. As it is generally agreed that an- 
timycin shifts to the red ferrocytochrome b-562 LY- 
absorption band [5], it is reasonable to assume that 
funiculosin brings about a blue shift of b-562 spec- 
trum of approximately the same magnitude. Also 
the derivative-shaped effect of NoHOQnO, first 
observed in [14], centred at 562 nm in the cry- and 
at 430 nm in the Soret band, can be ascribed provi- 
sionally to a red shift of ferrocytochrome b-562. 
Indeed, preliminary simulations of the difference 
spectra [l l] show that the effects observed in the a- 
band fit well to the ferrocytochrome b-562 a-peak 
(Lorentzian shape assumed [ 11,151) being shifted 
by 0.4-0.5 nm and 0.06 nm to the red by an- 
timycin and NoHOQnO, respectively, and by 
0.4-0.5 nm to the blue by funiculosin. 
Two comments are necessary due to the results 
obtained with myxothiazol and mucidin. First, we 
have found that with fresh preparations of com- 
plex bcl and at low detergent concentrations the 
spectral changes induced by myxothiazol are iden- 
tical with those observed in submitochondrial par- 
ticles [6,11,15] and different from those reported 
by Von Jagow and Engel for complex bcl [7]. 
However, a more or less symmetrical difference 
spectrum, similar to the one reported in [7] and 
closely resembling the effect of mucidin here 
(fig.lA,d) and in [14], could be observed occa- 
sionally with myxothiazol when aged preparations 
of complex bcl were used in experiments or the 
medium contained high concentrations of 
detergent. Second, the spectral effect of myx- 
othiazol in [7] (which is approximately equivalent 
to the effect of mucidin as mentioned above) was 
postulated without arguments to originate in,a red- 
shift of ferrocytochrome b-566 a-band [71. We 
would note, that the line shapes of the responses 
elicited by either myxothiazol or mucidin can hard- 
ly support this claim. Moreover, spectral simula- 
tions, MCD measurements and experiments at 
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Fig.1. Effects of bcr-site inhibitors on the optical absorption spectrum of the reduced cytochrome bcr complex in the 
visible (A) and Soret (B) region. The sample and reference cells contained 0.5 mg protein/ml of complex bcr in the basic 
medium to which l-2 mg solid dithionite was added. After correction of a baseline (-- -), an inhibitor was added to 
the sample and an equal volume of the solvent to the reference. Inhibitor concentrations: antimycin, 3 pM; NoHOQnO, 
20 PM; funiculosin, 8 ,uM; mucidin, 16tM; myxothiazol, 3.6pM. The mutual position of the baselines and 
corresponding difference spectra on the vertical axis have been chosen arbitrarily. The effect of antimycin on the ff,u,B- 
band of the oxidized complex bcr is also included in the figure ( - - -); in this case conditions are as in fig.2 except that 
concentration of complex bcr is 3.1 mg protein/ml and instrument sensitivity is 3-fold higher than indicated for the 
other spectra. 
controlled redox states of cytochromes b-566 and 
b-562 (the results will be described in a full-length 
paper in collaboration with A.M. Arutjunjan’s 
laboratory) all show consistently that the effects of 
mucidin and myxothiazol are dominated by the 
response of cytochrome b-562, with a minor con- 
tribution from b-566. 
The spectral changes induced by the antibiotics 
were further used here to study competition bet- 
ween the inhibitors for binding with the bcr-site. 
The results obtained are given in table 1 and can be 
summarized as follows: 
(i) Antimycin, funiculosin and NoHOQnO do not 
compete with myxothiazol and mucidin (see also 
t671). 
(ii) There is mutual competition between an- 
timycin, funiculosin and NoHOQnO for the bind- 
ing site; displacement of one inhibitor by the other 
could be observed in accordance with the binding 
97 
Volume 181, number 1 FEBS LETTERS February 1985 
b ..I___c.--- 
ri*5.554 
iwI 
I 
so0 420 MO bbo 
A. nm 
- 
Fig.2 Changes in the Soret band of the oxidized 
compfex bet induced by antimycin, funiculosin, mucidin 
and myxothiazol. Conditions as in fig.1, but the 
incubation medium contained 300 ph4 ferricyanide 
instead of dithionite. The effect of NoHOQnO is 
missing in the figure because of the artifactual 
absorbance changes brought about under these 
conditions by the inhibitor [12]. 
strength series antimycin > funiculosin > 
No~OQnO which agrees with the inhibitory effi- 
ciency of the antibiotics [5,it,l7,18]. 
(iii) Myxothiazof and mucidin compete with each 
other; displacement of mucidin by myxothi~o1 is 
probable since the latter binds the respiratory 
chain much more tightly 16, I If 191 but it is difficult 
to elicit it s~ectr~photometrically because the spec- 
tral changes induced by the two antibiotics do not 
differ enough from each other. 
In conclusion, the results given here allow us to 
divide the inhibitors studied into 2 groups. An- 
timycin, ~oHOQn0 and fnnic~losin compete for 
the same specific binding site and bring about spec- 
tral changes which can be attributed to cytochrome 
b-562. ~yxothi~ol and mucidin compete between 
themselves but not with the antimycin group and 
- 
Table 1 
Interdependence of the spectral effects of i?ct-site inhibitors 
Inhibitor present initialiy Induction of the spectral effect by the inhibitor added 
Antimy~in Funi~ulosin NoHOQnO Myxothiazol Mucidin 
Antimycin no no il0 yes yes 
Funieulosin yes’ no no yes yes 
NaHOQnO yes yesa no yes yes 
MyxothiazoI yes yes yes no nob 
Mucidin yes yes yes nob no 
’ A very slow displacement of the inhibitor present is initially observed 
b The data of the experiments in the Soret band where the spectral changes induced by mucidin and myxothiazol are 
virtually identical so that d~spiac~ment of one inhibitor by the other is not spectrophotometricaliy visible 
Conditions essentialfy as in fig.1 but the sample and reference cells contained initial& one of the inhibitors given in the 
left column, The baseline adjusted, a second inhibitor was added to the sample (and an equal volume of the solvent 
to the reference) and spectral response was registered 
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induce a more complex type of spectral change 
which probably involves contributions from both 
b-566 and b-562. This is in agreement with the Q- 
cycle scheme [20] according to which there can be 
2 different sites of action for the inhibitors of elec- 
tron transfer between cytochromes b and cl. An- 
timycin NoHOQnO and funiculosin are likely to 
inhibit cytochrome b-562 oxidation in centre i of 
the Q-cycle [3,11,20-221. Hence it may seem 
natural that they affect specifically the optical as 
well as redox [ 11,23,24] properties of cytochrome 
b-562. As to myxothiazol and mucidin, these are 
probably inhibitors of QH2 oxidation by FeS 
Rieske in centre o of the Q-cycle [21,25,26] (rather 
than of ubisemiquinone oxidation by b-566 as sug- 
gested in [7]); nevertheless, these antibiotics per- 
turb the spectra and redox potentials [11,24] of 
both cytochromes b. We would remark that the 
spectral or redox effects of various antibiotics on 
cytochromes b do not necessarily have to be direct 
and could well be mediated by the structural rear- 
rangements in complex bcl induced by these 
ligands. 
Finally, whatever the mechanism, intensive spec- 
tral changes produced by the inhibitors can be a 
simple and useful tool in the studies of their bind- 
ing with complex bcl in different oxidation states. 
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